Evidence map›Paper›PMID 30847994›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2019

The impact of new guidelines on the prevalence of hypertension in children: A cross-sectional evaluation.

Michelle Condren, Jessamyn Carter, Nasir Mushtaq, Scott Puckett, Krista Kezbers, Samie Sabet, Danielle Morgan

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Combining multiaspect factors to predict the risk of childhood hypertension incidence.Journal of clinical hypertension (Greenwich, Conn.) · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Michelle CondrenDepartment of Pediatrics, University of Oklahoma School of Community Medicine, Tulsa, Oklahoma.ORCID 0000-0002-9140-6676
Jessamyn CarterDepartment of Pediatrics, University of Oklahoma School of Community Medicine, Tulsa, Oklahoma.
Nasir MushtaqDepartment of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Tulsa, Oklahoma.
Scott PuckettUniversity of Oklahoma School of Community Medicine, Tulsa, Oklahoma.
Krista KezbersOffice for Research Development and Scholarly Activity, University of Oklahoma School of Community Medicine, Tulsa, Oklahoma.
Samie SabetDepartment of Pediatrics, University of Oklahoma School of Community Medicine, Tulsa, Oklahoma.
Danielle MorganDepartment of Pediatrics, University of Oklahoma School of Community Medicine, Tulsa, Oklahoma.
University of Oklahoma · USTulsa Community College · USUniversity of Oklahoma Health Sciences Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Robert Hal Scofield · 2013 to 2026
$68.2M
NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Updated clinical practice guidelines for screening blood pressures in pediatric patients were published in 2017. They differ from the previous guideline, known as the Fourth Report, providing updated population normal values and blood pressure categorization. We hypothesized that the prevalence of abnormal blood pressure in children and adolescents would be higher using the new clinical practice guidelines. We present a cross-sectional study of screening blood pressure values for children 3 to 18 years of age obtained during well-child visits at a primary care clinic. All blood pressure values were categorized using both the Fourth Report and the Clinical Practice Guideline. A total of 2635 blood pressure measurements were extracted, and 2600 were eligible for analysis. Using the clinical practice guideline, the prevalence of hypertension increased to 17.85% compared to 9.5% per the Fourth Report (P < 0.0001). Of those patients classified as having a normal blood pressure by the Fourth Report, 12% changed to abnormal when applying the Clinical Practice Guideline. All subgroups had a significant increase in the prevalence of abnormal blood pressure. The most dramatic increase in the prevalence of stage 1 and stage 2 hypertension was seen in six patient subgroups: males, 3-12 years of age, Hispanic ethnicity, race designated as other, normal weight, and overweight. Applying the new Clinical Practice Guideline increased the prevalence of elevated blood pressure and stage 1 and stage 2 hypertension in children and adolescents, requiring more follow-up and intervention than previously expected for this patient population.

Indexed as

AdolescentBlood PressureBlood Pressure DeterminationChildChild, PreschoolCross-Sectional StudiesFemaleHispanic or LatinoHumansHypertensionMaleMass ScreeningOverweightPractice Guidelines as TopicPrevalenceReference Valuesblood pressureguidelinespediatric

Identifiers

PMID30847994
PMCPMC8030632
OpenAlexW2921341918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.